{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:10:07Z","timestamp":1781208607025,"version":"3.54.1"},"reference-count":154,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1517\/14656566.6.5.723","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T07:16:32Z","timestamp":1115709392000},"page":"723-734","source":"Crossref","is-referenced-by-count":10,"title":["Erythropoietin: an update on the therapeutic use in newborn infants and children"],"prefix":"10.1517","volume":"6","author":[{"given":"Hugo","family":"Donato","sequence":"first","affiliation":[{"name":"Ocampo 3308 \u2013 1754 San Justo, Buenos AiresArgentinaFax: ;E-mail:"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,5,10]]},"reference":[{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/153537020322800101"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000092803.69761.41"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.08.012"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.5.8612498"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000163796"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13700.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110133"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3218"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01953935"},{"key":"e_1_2_1_12_1","first-page":"7850","article-title":"Cloning and expression of the human erythropoietin gene","volume":"92","author":"LIN FK","year":"1985","unstructured":"LIN FK, SUGGS S, LIN CH et al: Cloning and expression of the human erythropoietin gene. Proc. Nati Acad. Sci. USA (1985) 92:7850\u20137884.","journal-title":"Proc. Nati Acad. Sci. USA"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/313806a0"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198701083160203"},{"key":"e_1_2_1_15_1","first-page":"537","article-title":"Studies on erythrokinetics in infancy: III","volume":"52","author":"GARBY L","year":"1963","unstructured":"GARBY L, SJOLIN S et al: Studies on erythrokinetics in infancy: III. Plasma dissapearance and red cell uptake of intravenously injected radioiron. Acta Paediatr. (1963) 52:537\u2013540.","journal-title":"Plasma dissapearance and red cell uptake of intravenously injected radioiron. Acta Paediatr."},{"key":"e_1_2_1_16_1","first-page":"28","article-title":"Percentile curves for hemoglobin and red cell volume in infancy and childhood","volume":"94","author":"DALLMAN PR","year":"1979","unstructured":"DALLMAN PR, SIIMES MA: Percentile curves for hemoglobin and red cell volume in infancy and childhood. I Pediatr. (1979) 94:28\u201333.","journal-title":"I Pediatr."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80308-X"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(83)80600-3"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.11.2360.2360"},{"key":"e_1_2_1_20_1","first-page":"793","volume":"105","author":"BROWN MS","year":"1984","unstructured":"BROWN MS, GARCIA JF, PHIBBS RHet al.: Decreased response of plasma immunoreactive erythropoietin to 'available oxygen' in anemia of prematurity. I Pediatr: (1984) 105:793\u2013798.","journal-title":"PHIBBS RHet al.: Decreased response of plasma immunoreactive erythropoietin to 'available oxygen' in anemia of prematurity. I Pediatr"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199408000-00005"},{"key":"e_1_2_1_22_1","first-page":"F474","article-title":"Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia","volume":"263","author":"TAN CC","year":"1992","unstructured":"TAN CC, ECKARDT KU, FIRTH JD et al.: Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am. J. Physiol (1992) 263: F474\u2013481.","journal-title":"Am. J. Physiol"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2002.00745.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.2.e19"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30274-4"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80223-3"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82671-X"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82217-6"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80303-8"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02026707"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01957568"},{"key":"e_1_2_1_32_1","first-page":"269A","article-title":"Response of Rhesus monkeys to recombinant human erythropoietin: Comparison of adults and infants","volume":"25","author":"GEORGE JW","year":"1989","unstructured":"GEORGE JW, BRACCO C, SHANNONK et al.: Response of Rhesus monkeys to recombinant human erythropoietin: Comparison of adults and infants. Pediatr. Res. (1989) 25:269A.","journal-title":"Pediatr. Res."},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0022-3565(25)11173-7","article-title":"Developmental differences in erythropoietin pharmacokinetics: Increased clearance and distribution in fetal and neonatal sheep","volume":"261","author":"WIDNESS JA","year":"1992","unstructured":"WIDNESS JA, VENG-PEDERSEN P, MODI NB et al.: Developmental differences in erythropoietin pharmacokinetics: Increased clearance and distribution in fetal and neonatal sheep. Phannacol Exp. Ther. (1992) 261:977\u2013984.","journal-title":"Phannacol Exp. Ther."},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80659-6"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83559-0"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70363-3"},{"key":"e_1_2_1_37_1","first-page":"279","article-title":"Recombinant human erythropoietin in the treatment of anemia of prematurity: A randomized, double-blind, placebo-controlled trial comparing three different doses","volume":"3","author":"DONATO H","year":"1996","unstructured":"DONATO H, RENDO P, VIVAS N, SCHVARTZMAN G, DIGREGORIO J, VAIN N: Recombinant human erythropoietin in the treatment of anemia of prematurity: A randomized, double-blind, placebo-controlled trial comparing three different doses. Int J. Pediatr Heinatol Oncol (1996) 3:279\u2013285.","journal-title":"Int J. Pediatr Heinatol Oncol"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82552-1"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.3_Spec_No.291"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.93.6.918"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.95.1.1"},{"key":"e_1_2_1_42_1","unstructured":"\u2022\u2022This paper defmitely established theefectiveness of late epoetin administration to decrease transfusional requirement in AP."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301701"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70462-0"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70089-1"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.5.1066"},{"key":"e_1_2_1_47_1","unstructured":"\u2022\u2022This was the first paper comparing earlyversus late administration of epoetin in a large group of VLBW infants."},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2001.00667.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.4.934"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.124309"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211018"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70150-6"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(00)70105-3"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2003.00455.x"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39090938.x"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.125853"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(67)80416-5"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30925-4"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81096-0"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80092-7"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.90.5.678"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81704-4"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199907000-00116"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199605000-00015"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.5.F444"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1159\/000048000"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200101000-00018"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050340"},{"key":"e_1_2_1_69_1","first-page":"235","article-title":"A multicenter, randomized, double-blind trial with recombinant human erythropoietin (rHuEPO) in anemic HIV-infected children treated with antiretrovirals","volume":"7","author":"RENDO P","year":"2001","unstructured":"RENDO P, FREIGEIRO D, BARBONI G, DONATO H, DRELICHMAN G, GONZALEZ A: A multicenter, randomized, double-blind trial with recombinant human erythropoietin (rHuEPO) in anemic HIV-infected children treated with antiretrovirals. Intj Pediatr Heinatol Oncol (2001) 7:235\u2013239.","journal-title":"Intj Pediatr Heinatol Oncol"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199607000-00023"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200309260-00006"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70331-1"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.2.393"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200022"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2004.03.033"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199909000-00003"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2004.03.004"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401450"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2003.12.037"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.8.4635"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9748"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199906000-00007"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.3.422"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.19.10526"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1159\/000074970"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402029"},{"key":"e_1_2_1_87_1","unstructured":"\u2022\u2022This was the first study in which theneuroprotectant effect of epoetin was demonstrated in humans."},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1159\/000074958"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1159\/000068926"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2004.03.003"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2004.03.001"},{"key":"e_1_2_1_92_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-3782(98)00030-9","article-title":"Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus","volume":"52","author":"JUUL SE","year":"1998","unstructured":"JUUL SE, YACHNIS AT, CHRISTENSEN RD: Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum. Dev. (1998) 52:235\u2013249.","journal-title":"Early Hum. Dev."},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(00)90006-X"},{"key":"e_1_2_1_94_1","first-page":"281","article-title":"Enteral administration of recombinant erythropoietin to preterm infants","volume":"15","author":"BRITTON J","year":"1995","unstructured":"BRITTON J, CHISTENSEN R: Enteral administration of recombinant erythropoietin to preterm infants. Perinatol (1995) 15:281\u2013283.","journal-title":"Perinatol"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01222-2"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A439"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7210894"},{"key":"e_1_2_1_98_1","first-page":"392","article-title":"Tratamiento de la anemia en nifios sometidos a hemodidlisis cr\u00f6nica con eritropoyetina humana recombinante","volume":"54","author":"RENDO P","year":"1994","unstructured":"RENDO P, BISCIGNIANO L, TURCONI A, SANCHEZ AVALOS JC, GRECO J: Tratamiento de la anemia en nifios sometidos a hemodidlisis cr\u00f6nica con eritropoyetina humana recombinante. Medicine (1994) 54:392\u2013398.","journal-title":"Medicine"},{"key":"e_1_2_1_99_1","first-page":"207","article-title":"Treatment of anemia in hemodialyzed children using recombinant human erythropoietin (Eprex): Results of a French multicenter clinical trial","volume":"15","author":"GAGNADOUX MF","year":"1994","unstructured":"GAGNADOUX MF, LOIRAT C, BERTHELEME JP et al.: Treatment of anemia in hemodialyzed children using recombinant human erythropoietin (Eprex): Results of a French multicenter clinical trial. Nephrologie (1994) 15:207\u2013211.","journal-title":"Nephrologie"},{"key":"e_1_2_1_100_1","first-page":"S182\u2013S238","article-title":"K\/DOQI Clinical practice guidelines for anemia of chronic kidney disease, 2000","volume":"37","author":"NATIONAL KIDNEY FOUNDATION","year":"2001","unstructured":"NATIONAL KIDNEY FOUNDATION: K\/DOQI Clinical practice guidelines for anemia of chronic kidney disease, 2000. Am. J. Kidney Dis. (2001) 37:S182\u2013S238.","journal-title":"Am. J. Kidney Dis."},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00866354"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443010-00004"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280304"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1159\/000418719"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00357.x"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90192-X"},{"key":"e_1_2_1_107_1","first-page":"805","article-title":"Pediatric Peritoneal Dialysis Working Group: The management of anemia in pediatric peritoneal dialysis patients","volume":"18","author":"SCHRODER CH","year":"2003","unstructured":"SCHRODER CH: The European Pediatric Peritoneal Dialysis Working Group: The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr. Nephrol (2003) 18:805\u2013809.","journal-title":"Guidelines by an ad hoc European committee. Pediatr. Nephrol"},{"key":"e_1_2_1_108_1","first-page":"200","article-title":"The use of subcutaneous erythropoietin in CAPD patients","volume":"33","author":"PIRAINO B","year":"1990","unstructured":"PIRAINO B, JOHNSTON JR: The use of subcutaneous erythropoietin in CAPD patients. Clia Nephrol (1990) 33:200\u2013211.","journal-title":"Clia Nephrol"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36910"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2003.00042.x"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91662-0"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050443"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90318-2"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1159\/000058411"},{"key":"e_1_2_1_115_1","first-page":"1183","article-title":"Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report","volume":"22","author":"CITARRELLA P","year":"2002","unstructured":"CITARRELLA P, GEBBIA V, TERESI M et al.: Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report. Anti-Cancer Res. (2002) 22:1183\u20131185.","journal-title":"Anti-Cancer Res."},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196107202650303"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80567-2"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90012-Z"},{"key":"e_1_2_1_119_1","first-page":"F812\u2013F815","article-title":"Erythropoietin metabolism and pharmacokinetics in experimental nephrosis","volume":"263","author":"ZHOU KJ","year":"1992","unstructured":"ZHOU KJ, VAZIRI ND: Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Ain. Physiol Renal Physiol (1992) 263: F812\u2013F815.","journal-title":"Ain. Physiol Renal Physiol"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80122-0"},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90313-3"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1159\/000189460"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.7.1895"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.25174"},{"key":"e_1_2_1_125_1","doi-asserted-by":"crossref","unstructured":"KNIGHT K WADE S BALDUCCI L: Prevalence and outcomes of anemia in cancer: A systematic review of the literature. Am. J. Med. (2004) 116:11S\u201326S.","DOI":"10.1016\/j.amjmed.2003.12.008"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10183"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006143222401"},{"key":"e_1_2_1_128_1","first-page":"563","volume":"30","author":"FERRARIO E","year":"2004","unstructured":"FERRARIO E, FERRARI L, BID OLI P et al.: Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat. Rev (2004) 30:563\u2013575.","journal-title":"BID OLI P et al.: Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat. Rev"},{"key":"e_1_2_1_129_1","unstructured":"\u2022\u2022This study provides an excellent review ofthe impact of epoetin on quality of life and transfusion requirements in patients with cancer."},{"key":"e_1_2_1_130_1","doi-asserted-by":"crossref","unstructured":"AAPRO M SAN MIGUEL J: Evolving treatment strategies for anaemia in cancer: experience with epoetin beta. Oncology (2004) 67\\(Suppl. 1):17\u201322.","DOI":"10.1159\/000080704"},{"key":"e_1_2_1_131_1","unstructured":"\u2022This trial clearly established the impact of epoetin on quality of life and transfusion requirements in patients with cancer."},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1218"},{"key":"e_1_2_1_133_1","unstructured":"\u2022This trial clearly established the impact of epoetin on quality of life and transfusion requirements in patients with cancer."},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3412"},{"key":"e_1_2_1_135_1","unstructured":"\u2022This trial clearly established the impact of epoetin on quality of life and transfusion requirements in patients with cancer."},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.07.177"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.07.015"},{"key":"e_1_2_1_138_1","first-page":"2875","article-title":"Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing","volume":"19","author":"GABRILOVE JL","year":"2001","unstructured":"GABRILOVE JL, CLEELAND CS, LIVINGSTON RB, SAROKHAN B, WINER E, EINHORN LH: Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. Oncol (2001) 19:2875\u20132882.","journal-title":"Oncol"},{"key":"e_1_2_1_139_1","doi-asserted-by":"crossref","unstructured":"BOHLIUS J LANGENSIEPEN S SCHWRZER G et al.: Erythropoietin for patients with malignant disease (Cochrane Review): In: The Cochrane Library Issue 3 John Wiley & Sons Chichester (2004).","DOI":"10.1002\/14651858.CD003407.pub2"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10187"},{"key":"e_1_2_1_141_1","first-page":"1","article-title":"A single institutional experience: is epoetin alpha effective in anemic children with cancer? Pediatr","volume":"21","author":"YILMAZ D","year":"2004","unstructured":"YILMAZ D, CETIMGUL N, KANTAR M, ONIZ H, KANSOY S, KAVAKLI K: A single institutional experience: is epoetin alpha effective in anemic children with cancer? Pediatr. Hematol Oncol (2004) 21:1\u20138:","journal-title":"Hematol Oncol"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10186"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10185"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880010252825687"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.002"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.301"},{"key":"e_1_2_1_147_1","first-page":"S304\u2013S314","article-title":"Anemia in the setting of cancer and human immunodeficiency virus","volume":"37","author":"LEVINE AM","year":"2003","unstructured":"LEVINE AM: Anemia in the setting of cancer and human immunodeficiency virus. Chit. Infect. Dis. (2003) 37:S304\u2013S314.","journal-title":"Chit. Infect. Dis."},{"key":"e_1_2_1_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80081-8"},{"key":"e_1_2_1_149_1","doi-asserted-by":"crossref","unstructured":"BELPERIO PS PHARM D RHEW DC: Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: A systematic review of the literature. Am. J. Med. (2004) 116:27S\u201343S.","DOI":"10.1016\/j.amjmed.2003.12.010"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03359.x"},{"key":"e_1_2_1_151_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-9-739"},{"key":"e_1_2_1_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(97)00371-3"},{"key":"e_1_2_1_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30137-0"},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.027"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2003.06.010"},{"key":"e_1_2_1_156_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040528"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.6.5.723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:01:34Z","timestamp":1772730094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.6.5.723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":154,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1517\/14656566.6.5.723"],"URL":"https:\/\/doi.org\/10.1517\/14656566.6.5.723","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}